✦ LIBER ✦

Randomized Phase III Trial of Gemcitabine Compared With Pegylated Liposomal Doxorubicin in Patients With Platinum-Resistant Ovarian Cancer

✍ Scribed by Mutch, D. G.; Orlando, M.; Goss, T.; Teneriello, M. G.; Gordon, A. N.; McMeekin, S. D.; Wang, Y.; Scribner, D. R.; Marciniack, M.; Naumann, R. W.; Secord, A. A.

Book ID: 121342766
Publisher: American Society of Clinical Oncology
Year: 2007
Tongue: English
Weight: 325 KB
Volume: 25
Category: Article
ISSN: 0732-183X
DOI: 10.1200/JCO.2006.09.6735

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Trial in progress: A randomized double-b

Trial in progress: A randomized double-blind phase 3 trial comparing vintafolide+pegylated liposomal doxorubicin (PLD) versus PLD+placebo in patients with platinum-resistant ovarian cancer (PROCEED)

✍ Naumann, R.W.; Gilbert, L.; Habbe, A.; Ma, H.; Ghamande, S.; Vergote, I.B. 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Phase 1/2 Study of Atrasentan Combined w

Phase 1/2 Study of Atrasentan Combined with Pegylated Liposomal Doxorubicin in Platinum-Resistant Recurrent Ovarian Cancer

✍ Witteveen, Petronella O.; van der Mijn, Koen J.C.; Los, Maartje; Kronemeijer, Ro 📂 Article 📅 2010 🏛 Neoplasia Press 🌐 English ⚖ 147 KB

Pegylated liposomal doxorubicin with bev

Pegylated liposomal doxorubicin with bevacizumab in the treatment of platinum-resistant ovarian cancer: Toxicity profile results

✍ S. Czok; A. Jewell; S. Shawki; L. Boyd; H. Smith; S. Blank; C. Muller; C. Versch 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Gemcitabine and pegylated liposomal doxo

Gemcitabine and pegylated liposomal doxorubicin alternating with cisplatin plus cyclophosphamide in platinum refractory/resistant, paclitaxel-pretreated, ovarian carcinoma

✍ Dimitrios Pectasides; Nicolaos Xiros; George Papaxoinis; Gerasimos Aravantinos; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 182 KB

Meta-analysis of trials comparing gemcit

Meta-analysis of trials comparing gemcitabine and pegylated liposomal doxorubicin for treatment in women with progressive or recurrent ovarian cancer

✍ Xia Liu; Li Ma; Jinhui Tian; Kehu Yang 📂 Article 📅 2009 🏛 Springer-Verlag ⚖ 338 KB

Phase II study of bevacizumab with lipos

Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer

✍ Verschraegen, C. F.; Czok, S.; Muller, C. Y.; Boyd, L.; Lee, S. J.; Rutledge, T. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 144 KB